DRUGS IN SPORTS
DOI:
https://doi.org/10.15547/tjs.2025.4.015Keywords:
Doping, athletic performance, WADA, banned substances, control and regulationAbstract
The use of doping - medications intended to artificially enhance athletic performance, remains a serious and widespread phenomenon in elite sports, despite strict prohibitions. The World Anti-Doping Agency (WADA) annually updates its list of banned substances and monitors their use through blood and urine testing, conducted by certified laboratories using proven methods, such as gas chromatography and mass spectrometry.
Despite these efforts, violations persist, and the list of substances used continues to grow and diversify. The main groups of doping agents include: anabolic steroids, hormones, stimulants, beta-blockers, diuretics and analgesics.
Gene doping is a new and difficult-to-detect form of doping which raises serious ethical and health concerns and requires new approaches for detection and control.
Conclusion. Doping remains a significant and multifaceted problem in modern sports. Despite strict bans and evolving control methods, athletes and coaches often rely on substances with limited scientifically proven effectiveness, which pose numerous health hazards. The emergence of new technologies, such as gene doping further complicates the situation. More effective regulations, increased awareness, and a strictly scientific approach are essential in the fight against doping.
References
James M. Ritter, Rod Flower. Lifestyle and drugs in sport. Rang & Dale's Pharmacology. 9th ed., Elsevier, pp. 744-749, 2020.
Mottram, D.R. (Ed.). Drugs in Sport, fourth ed. Routledge, London, 2018.
Sparling, P.B. The Lance Armstrong saga: a wake-up call for drug reform in sports. Curr. Sports Med. Rep. 12, 53–54, 2013.
Gould, D. Gene doping: gene delivery for Olympic victory. Br. J. Clin. Pharmacol. 76, 292–298, 2013.
Catlin, D.H., Fitch, K.D., Ljungqvist, A. Medicine and science in the fight against doping in sport. J. Intern. Med. 264, 99–114, 2008.
Avois, L., Robinson, N., Saudan, C., et al. Central nervous system stimulants and sport practice. Br. J. Sports Med. 40 (Suppl. 1), 16–20, 2006.
Savulescu, J., Foddy, B., Clayton, M. Why we should allow performance enhancing drugs in sport. Br. J. Sports Med. 38, 666–670, 2004.
British Medical Association. Drugs in Sport: The Pressure to Perform. BMJ Publications, London, 2002.
Munby, J. Drugs in sport. Scot. Med. J. 55, 29–30, 2010.
Spedding, M., Spedding, C., Drugs in sport: a scientist–athlete’s perspective: from ambition to neurochemistry. Br. J. Pharmacol. 154, 496–501, 2008.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.